University of California San Francisco

Adam Oskowitz Headshot
Adam
Oskowitz
MD, PhD

Associate Professor of Surgery
Division of Vascular and Endovascular Surgery
Department of Surgery, School of Medicine
University of California, San Francisco

Academic Office:
400 Parnassus Ave, A581, Box 0222
San Francisco, CA 94143
Tel: 415-353-4366
Email: [email protected]
Asst: [email protected]

Vascular Surgery Clinic at ZSFG
1001 Potrero Ave, Building 5, Room 3M
San Francisco, CA 94110
Tel: 415-206-8673
Fax: 415-206-2597

Biography

Dr. Adam Oskowitz is a vascular surgeon with extensive experience in evaluating and caring for patients in the clinic and during hospitalization. He plans and performs both basic and complex surgeries to address vascular disease.

In research, Oskowitz is interested in using stem cells to develop novel treatments for aortic aneurysms.

Oskowitz earned a master's degree in public health from Dartmouth College. He earned his medical and doctoral degrees at Tulane University. He completed his general surgery residency at the University of California, Los Angeles, where he served as chief resident. He also completed a fellowship in vascular surgery at UCLA.

Education

Institution Degree Dept or School End Date
UCLA Medical Center Fellowship Vascular surgery 2016
UCLA Medical Center Residency 2014
Tulane University School of Medicine 2009

Board Certifications

American Board of Surgery, General Surgery

Clinical Expertise

Abdominal Aortic Aneurysm

Aortic Dissection

Aortic Arch Aneurysms

Carotid Artery Disease

Complex Limb Revascularization

Complex Endovascular Aortic Repair

Dialysis Access

Endovascular Aneurysm Repair

Marfan Syndrome

Mesenteric Artery Disease

Peripheral Artery Disease

Thoracic Aortic Aneurysm

Venous Obstructive Disease

Visceral Artery Aneurysm

 

Research Narrative

Dr. Oskowitz is interested in developing novel treatments for Aortic Aneurysms using stem cells. His is currently studying the molecular mechanisms that govern the therapeutic benefits of stem cells while developing unique ways to utilize cell based therapy.

Research Interests

Aortic Aneurysms

Stem Cell Biology

Biologic Scaffolds and Stents

Research Pathways

Basic Biomedical & Translational Research

Publications

MOST RECENT PUBLICATIONS FROM A TOTAL OF 35
  1. Effective Treatment of Disseminated Prostate Cancer Using CD46-Targeted 225Ac Therapy.
    Bidkar AP, Peter R, Wadhwa A, Bobba KN, Bidlingmaier S, Meher N, Chou J, Greenland N, Dasari C, Naik S, Raveendran A, Basak M, Camara Serrano JA, Steri V, Kogan S, Oskowitz A, He J, Wilson DM, Aggarwal R, Sriram R, VanBrocklin HF, Seo Y, Liu B, Flavell RR| | PubMed
  2. PET Imaging Using 89Zr-Labeled StarPEG Nanocarriers Reveals Heterogeneous Enhanced Permeability and Retention in Prostate Cancer.
    Meher N, Bidkar AP, Wadhwa A, Bobba KN, Dhrona S, Dasari C, Mu C, Fong COY, Cámara JA, Ali U, Basak M, Bulkley D, Steri V, Fontaine SD, Zhu J, Oskowitz A, Aggarwal RR, Sriram R, Chou J, Wilson DM, Seo Y, Santi DV, Ashley GW, VanBrocklin HF, Flavell RR| | PubMed
  3. Vein distensibility is superior to vein diameter for predicting unassisted maturation of arteriovenous fistulae Presented at the Scientific Sessions of the Western Vascular Society Thirty-eighth Annual Meeting, Kauai, Hawaii, September 9-12, 2023.
    Curtis Woodford, Devin Zarkowsky, Bian Wu, Adam Z. Oskowitz, Robert Shahverdyan, Shant M. Vartanian| | UCSF Research Profile
  4. 3D small-scale dosimetry and tumor control of 225Ac radiopharmaceuticals for prostate cancer.
    Peter R, Bidkar AP, Bobba KN, Zerefa L, Dasari C, Meher N, Wadhwa A, Oskowitz A, Liu B, Miller BW, Vetter K, Flavell RR, Seo Y| | PubMed
  5. Vein distensibility is superior to vein diameter for predicting unassisted maturation of arteriovenous fistulae.
    Woodford C, Zarkowsky D, Wu B, Oskowitz AZ, Shahverdyan R, Vartanian SM| | PubMed
  6. Prostate-Specific Membrane Antigen Targeted StarPEG Nanocarrier for Imaging and Therapy of Prostate Cancer.
    Meher N, Ashley GW, Bobba KN, Wadhwa A, Bidkar AP, Dasari C, Mu C, Sankaranarayanan RA, Serrano JAC, Raveendran A, Bulkley DP, Aggarwal R, Greenland NY, Oskowitz A, Wilson DM, Seo Y, Santi DV, VanBrocklin HF, Flavell RR| | PubMed
  7. Vein Compliance is Superior to Vein Diameter for Predicting Unassisted AVF Maturation.
    C. Woodford, D. Zarkowsky, A.Z. Oskowitz, R. Shahverdyan, B. Wu, S.M. Vartanian| | UCSF Research Profile
  8. Patients with abdominal aortic aneurysms have reduced levels of microRNA 122-5p in circulating exosomes.
    Lopez JL, Ramirez JL, Phu TA, Duong P, Bouchareychas L, Kuhrau CR, Lin PY, Eckalbar WL, Barczak AJ, Rudolph JD, Maliskova L, Conte MS, Vartanian SM, Raffai RL, Oskowitz AZ| | PubMed
  9. A Chimeric Antigen Receptor Targeting Malonaldehyde-modified Low-density lipoprotein Cholesterol Activates Regulatory T Cells in the Presence of Human Atherosclerotic Plaque.
    Sonali Shaligram, Jose Luis Lopez, Pei-Yu Lin, Patrick Ho, April Huang, Qizhi Tang, Adam Z. Oskowitz| | UCSF Research Profile
  10. Regulatory T Cells Suppress Aortic Aneurysm Growth in Mice through Local Tissue Changes and Lymph Node Colonization.
    Jose Luis Lopez, Pei-Yu Lin, Sonali Shaligram, April Huang, Pierce Hadley, Qizhi Tang, Adam Oskowitz| | UCSF Research Profile
35
View all 35 Publications
MOST RECENT PUBLICATIONS FROM A TOTAL OF 35
  1. Effective Treatment of Disseminated Prostate Cancer Using CD46-Targeted 225Ac Therapy.
    Bidkar AP, Peter R, Wadhwa A, Bobba KN, Bidlingmaier S, Meher N, Chou J, Greenland N, Dasari C, Naik S, Raveendran A, Basak M, Camara Serrano JA, Steri V, Kogan S, Oskowitz A, He J, Wilson DM, Aggarwal R, Sriram R, VanBrocklin HF, Seo Y, Liu B, Flavell RR| | PubMed
  2. PET Imaging Using 89Zr-Labeled StarPEG Nanocarriers Reveals Heterogeneous Enhanced Permeability and Retention in Prostate Cancer.
    Meher N, Bidkar AP, Wadhwa A, Bobba KN, Dhrona S, Dasari C, Mu C, Fong COY, Cámara JA, Ali U, Basak M, Bulkley D, Steri V, Fontaine SD, Zhu J, Oskowitz A, Aggarwal RR, Sriram R, Chou J, Wilson DM, Seo Y, Santi DV, Ashley GW, VanBrocklin HF, Flavell RR| | PubMed
  3. Vein distensibility is superior to vein diameter for predicting unassisted maturation of arteriovenous fistulae Presented at the Scientific Sessions of the Western Vascular Society Thirty-eighth Annual Meeting, Kauai, Hawaii, September 9-12, 2023.
    Curtis Woodford, Devin Zarkowsky, Bian Wu, Adam Z. Oskowitz, Robert Shahverdyan, Shant M. Vartanian| | UCSF Research Profile
  4. 3D small-scale dosimetry and tumor control of 225Ac radiopharmaceuticals for prostate cancer.
    Peter R, Bidkar AP, Bobba KN, Zerefa L, Dasari C, Meher N, Wadhwa A, Oskowitz A, Liu B, Miller BW, Vetter K, Flavell RR, Seo Y| | PubMed
  5. Vein distensibility is superior to vein diameter for predicting unassisted maturation of arteriovenous fistulae.
    Woodford C, Zarkowsky D, Wu B, Oskowitz AZ, Shahverdyan R, Vartanian SM| | PubMed
  6. Prostate-Specific Membrane Antigen Targeted StarPEG Nanocarrier for Imaging and Therapy of Prostate Cancer.
    Meher N, Ashley GW, Bobba KN, Wadhwa A, Bidkar AP, Dasari C, Mu C, Sankaranarayanan RA, Serrano JAC, Raveendran A, Bulkley DP, Aggarwal R, Greenland NY, Oskowitz A, Wilson DM, Seo Y, Santi DV, VanBrocklin HF, Flavell RR| | PubMed
  7. Vein Compliance is Superior to Vein Diameter for Predicting Unassisted AVF Maturation.
    C. Woodford, D. Zarkowsky, A.Z. Oskowitz, R. Shahverdyan, B. Wu, S.M. Vartanian| | UCSF Research Profile
  8. Patients with abdominal aortic aneurysms have reduced levels of microRNA 122-5p in circulating exosomes.
    Lopez JL, Ramirez JL, Phu TA, Duong P, Bouchareychas L, Kuhrau CR, Lin PY, Eckalbar WL, Barczak AJ, Rudolph JD, Maliskova L, Conte MS, Vartanian SM, Raffai RL, Oskowitz AZ| | PubMed
  9. A Chimeric Antigen Receptor Targeting Malonaldehyde-modified Low-density lipoprotein Cholesterol Activates Regulatory T Cells in the Presence of Human Atherosclerotic Plaque.
    Sonali Shaligram, Jose Luis Lopez, Pei-Yu Lin, Patrick Ho, April Huang, Qizhi Tang, Adam Z. Oskowitz| | UCSF Research Profile
  10. Regulatory T Cells Suppress Aortic Aneurysm Growth in Mice through Local Tissue Changes and Lymph Node Colonization.
    Jose Luis Lopez, Pei-Yu Lin, Sonali Shaligram, April Huang, Pierce Hadley, Qizhi Tang, Adam Oskowitz| | UCSF Research Profile
  11. Abstract 124: Regulatory T Cells Suppress Aortic Aneurysm Growth In Mice Through Local Tissue Changes And Lymph Node Colonization.
    Jose L Lopez, Pei-Yu Lin, Sonali Shaligram, April Huang, Pierce Hadley, Qizhi Tang, Adam Z Oskowitz| | UCSF Research Profile
  12. Abstract 128: A Chimeric Antigen Receptor Targeting MDA-LDL Activates Regulatory T Cells In The Presence Of Human Atherosclerotic Plaque.
    Sonali Shaligram, Jose L Lopez, Pei-Yu Lin, Patrick Ho, April Huang, Qizhi Tang, Adam Z Oskowitz| | UCSF Research Profile
  13. Toward endovascular treatment of type A aortic dissection with smaller landing zones and more patient eligibility.
    Wisneski AD, Kumar V, Vartanian SM, Oskowitz AZ| | PubMed
  14. Abstract 15839: Patients With Abdominal Aortic Aneurysms Have Reduced Levels of MicroRNA 122-5p in Circulating Exosomes.
    Jose L Lopez, Joel L Ramirez, Tuan Anh Phu, Phat Duong, Laura Bouchareychas, Christina R Kuhrau, Pei Yu Lin, Michael S Conte, Shant M Vartanian, Robert L Raffai, Adam Z Oskowitz| | UCSF Research Profile
  15. Impact of the coronavirus disease 2019 pandemic on an academic vascular practice and a multidisciplinary limb preservation program.
    Lancaster EM, Wu B, Iannuzzi J, Oskowitz A, Gasper W, Vartanian S, Wick E, Hiramoto J, Eichler C, Lobo E, Reyzelman A, Reilly L, Sosa JA, Conte MS| | PubMed
  16. Toward Endovascular Treatment of Type A Aortic Dissection: Smaller Landing Zones, More Patient Eligibility.
    Andrew David Wisneski, Vishal Kumar, Shant Vartanian, Adam Z. Oskowitz| | UCSF Research Profile
  17. Natural history of acute pediatric iliofemoral artery thrombosis treated with anticoagulation.
    Ramirez JL, Kuhrau CR, Wu B, Zarkowsky DS, Conte MS, Oskowitz AZ, Nijagal A, Vartanian SM| | PubMed
  18. Circulating exosomes from patients with peripheral artery disease influence vascular cell migration and contain distinct microRNA cargo.
    Sorrentino TA, Duong P, Bouchareychas L, Chen M, Chung A, Schaller MS, Oskowitz A, Raffai RL, Conte MS| | PubMed
  19. Functional outcomes of arteriovenous fistulas recruited with regional anesthesia.
    Zarkowsky DS, Wu B, Gray AT, Oskowitz AZ, Vartanian SM| | PubMed
  20. Natural History of Acute Pediatric Iliofemoral Artery Thrombosis Treated With Antithrombotic Therapy.
    Joel L. Ramirez, Christina Kurhau, Bian Wu, Devin S. Zarkowsky, Michael S. Conte, Adam Z. Oskowitz, Amar Nijagal, Shant M. Vartanian| | UCSF Research Profile
  21. Arteriovenous Fistulas Recruited With Regional Anesthesia Have Comparable Functional Outcomes.
    Bian Wu, Devin S. Zarkowsky, Justin Inman, Andrew T. Gray, Adam Z. Oskowitz, Shant M. Vartanian| | UCSF Research Profile
  22. Abstract 109: Exosomes from Mesenchymal Stem Cells Suppress Aortic Elastin Induced Inflammation in Macrophages.
    Adam Oskowitz, Michael Conte| | UCSF Research Profile
  23. Infrarenal aortic repair with or without false lumen intentional placement of endografts for hybrid management of complex aortic dissection.
    Quinones-Baldrich WJ, Saleem T, Oskowitz A| | PubMed
  24. Contemporary outcomes after venography-guided treatment of patients with May-Thurner syndrome.
    Rollo JC, Farley SM, Oskowitz AZ, Woo K, DeRubertis BG| | PubMed
  25. Infrarenal Aortic Repair With or Without False Lumen Intentional Placement of Endografts for Hybrid Management of Complex Aortic Disease.
    William J. Quinones-Baldrich, Taimur Saleem, Adam Oskowitz| | UCSF Research Profile
  26. Contemporary Outcomes of Elective Iliac Vein Stenting in Chronic Venous Occlusive Disease.
    Johnathon C. Rollo, Steven Farley, Adam Oskowitz, Warren Chow, Juan Carlos Jimenez, Brian Derubertis| | UCSF Research Profile
  27. Contemporary Outcomes Following Imaging-Guided Treatment of Patients With May-Thurner Syndrome.
    Johnathon C. Rollo, Steven Farley, Adam Oskowitz, Juan Carlos Jimenez, Brian DeRubertis| | UCSF Research Profile
  28. Hybrid treatment of aortic arch aneurysms.
    Oskowitz AZ, Archie M, Archie M, Quinones-Baldrich W| | PubMed
  29. Drosha regulates hMSCs cell cycle progression through a miRNA independent mechanism.
    Oskowitz AZ, Penfornis P, Tucker A, Prockop DJ, Pochampally R| | PubMed
  30. Activation of autophagy in mesenchymal stem cells provides tumor stromal support.
    Sanchez CG, Penfornis P, Oskowitz AZ, Boonjindasup AG, Cai DZ, Dhule SS, Rowan BG, Kelekar A, Krause DS, Pochampally RR| | PubMed
  31. Human mesenchymal stromal cells (MSCs) reduce neointimal hyperplasia in a mouse model of flow-restriction by transient suppression of anti-inflammatory cytokines.
    Shoji M, Oskowitz A, Malone CD, Prockop DJ, Pochampally R| | PubMed
  32. Serum-deprived human multipotent mesenchymal stromal cells (MSCs) are highly angiogenic.
    Oskowitz A, McFerrin H, Gutschow M, Carter ML, Pochampally R| | PubMed
  33. Epigenetic reprogramming of IGF1 and leptin genes by serum deprivation in multipotential mesenchymal stromal cells.
    Sanchez C, Oskowitz A, Pochampally RR| | PubMed
  34. Human multipotent stromal cells from bone marrow and microRNA: regulation of differentiation and leukemia inhibitory factor expression.
    Oskowitz AZ, Lu J, Penfornis P, Ylostalo J, McBride J, Flemington EK, Prockop DJ, Pochampally R| | PubMed
  35. CREB phosphorylation and c-Fos expression in the hippocampus of rats during acquisition and recall of a socially transmitted food preference.
    Countryman RA, Orlowski JD, Brightwell JJ, Oskowitz AZ, Colombo PJ| | PubMed